PureTech Health plc (LON:PRTC)
London · Delayed Price · Currency is GBP · Price in GBX 117.00
+0.60 (0.52%)
Sep 5, 2025, 4:39 PM BST
PureTech Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 6.39 | 4.83 | 3.33 | 15.62 | 17.39 | 11.77 | Upgrade | |
Revenue Growth (YoY) | 1265.60% | 44.98% | -78.68% | -10.18% | 47.76% | 20.00% | Upgrade |
Cost of Revenue | 55.2 | 69.23 | 94.98 | 152.43 | 110.47 | - | Upgrade |
Gross Profit | -48.81 | -64.4 | -91.65 | -136.82 | -93.08 | 11.77 | Upgrade |
Selling, General & Admin | 68.59 | 71.47 | 53.3 | 60.99 | 57.2 | 49.44 | Upgrade |
Research & Development | - | - | - | - | - | 81.86 | Upgrade |
Operating Expenses | 68.59 | 71.47 | 53.3 | 60.99 | 57.2 | 131.3 | Upgrade |
Operating Income | -117.4 | -135.87 | -144.94 | -197.81 | -150.28 | -119.53 | Upgrade |
Interest Expense | - | -10.04 | -13.49 | -3.95 | -4.71 | -2.95 | Upgrade |
Interest & Investment Income | 18.58 | 22.67 | 16.01 | 5.8 | 0.21 | 1.18 | Upgrade |
Earnings From Equity Investments | -9.39 | -8.75 | -6.06 | -27.75 | -73.7 | -34.12 | Upgrade |
Currency Exchange Gain (Loss) | -0.01 | -0.03 | -0.09 | 0.01 | -0.06 | - | Upgrade |
Other Non Operating Income (Expenses) | -5.16 | -7.15 | 1.74 | 145.19 | 11.2 | -3.32 | Upgrade |
EBT Excluding Unusual Items | -113.38 | -139.16 | -146.82 | -78.5 | -217.34 | -158.73 | Upgrade |
Gain (Loss) on Sale of Investments | -3.53 | 11.08 | 50.19 | -41.53 | 158.39 | 177.7 | Upgrade |
Gain (Loss) on Sale of Assets | 151.81 | 151.81 | 61.79 | 27.25 | - | - | Upgrade |
Asset Writedown | -0.23 | -0.23 | -1.26 | - | - | - | Upgrade |
Other Unusual Items | 0.27 | 0.27 | - | - | - | - | Upgrade |
Pretax Income | 34.95 | 23.77 | -36.1 | -92.78 | -58.95 | 18.97 | Upgrade |
Income Tax Expense | 3.06 | -4.01 | 30.53 | -55.72 | 3.76 | 14.4 | Upgrade |
Earnings From Continuing Operations | 31.89 | 27.78 | -66.63 | -37.06 | -62.71 | 4.57 | Upgrade |
Minority Interest in Earnings | 18.79 | 25.73 | 0.93 | -13.29 | 2.15 | 1.42 | Upgrade |
Net Income | 50.68 | 53.51 | -65.7 | -50.35 | -60.56 | 5.99 | Upgrade |
Net Income to Common | 50.68 | 53.51 | -65.7 | -50.35 | -60.56 | 5.99 | Upgrade |
Net Income Growth | - | - | - | - | - | -98.58% | Upgrade |
Shares Outstanding (Basic) | 240 | 254 | 276 | 285 | 287 | 286 | Upgrade |
Shares Outstanding (Diluted) | 241 | 256 | 276 | 285 | 287 | 293 | Upgrade |
Shares Change (YoY) | -11.33% | -7.34% | -2.97% | -0.64% | -2.14% | 0.37% | Upgrade |
EPS (Basic) | 0.21 | 0.21 | -0.24 | -0.18 | -0.21 | 0.02 | Upgrade |
EPS (Diluted) | 0.20 | 0.21 | -0.24 | -0.18 | -0.21 | 0.02 | Upgrade |
EPS Growth | - | - | - | - | - | -98.61% | Upgrade |
Free Cash Flow | -100.31 | -134.38 | -105.99 | -180.97 | -163.85 | -137 | Upgrade |
Free Cash Flow Per Share | -0.42 | -0.53 | -0.38 | -0.64 | -0.57 | -0.47 | Upgrade |
Gross Margin | - | - | - | - | - | 100.00% | Upgrade |
Operating Margin | -1837.00% | -2814.19% | -4352.55% | -1266.53% | -864.29% | -1015.73% | Upgrade |
Profit Margin | 792.96% | 1108.33% | -1972.88% | -322.41% | -348.27% | 50.86% | Upgrade |
Free Cash Flow Margin | -1569.52% | -2783.35% | -3182.79% | -1158.71% | -942.29% | -1164.15% | Upgrade |
EBITDA | -115.72 | -134.06 | -141.99 | -191.96 | -145.93 | -115.59 | Upgrade |
D&A For EBITDA | 1.69 | 1.81 | 2.95 | 5.85 | 4.35 | 3.95 | Upgrade |
EBIT | -117.4 | -135.87 | -144.94 | -197.81 | -150.28 | -119.53 | Upgrade |
Effective Tax Rate | 8.76% | - | - | - | - | 75.92% | Upgrade |
Revenue as Reported | 6.39 | 4.83 | 3.33 | 15.62 | 17.39 | 11.77 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.